$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
纳武利尤单抗 用法用量
2025-10-19 11:44:20
Check Details
纳武利尤单抗的使用说明
2025-10-19 11:44:20
Check Details
O药可治疗什么病症?
2025-10-19 11:44:20
Check Details
O药价格多少呢?
2025-10-19 11:44:20
Check Details
Opdivo是什么药物?
2025-10-19 11:44:20
Check Details
Opdivo医保吗?
2025-10-19 11:44:20
Check Details
Nivolumab治疗效果如何呢?
2025-10-19 11:44:20
Check Details
用Nivolumab要注意什么事项?
2025-10-19 11:44:20
Check Details
Opdyta是什么呢?
2025-10-19 11:44:20
Check Details
Opdyta效果好吗?
2025-10-19 11:44:20
Check Details
拉罗替尼适应症
2025-10-19 11:44:20
Check Details
拉罗替尼的说明书
2025-10-19 11:44:20
Check Details
1
2
...
365
366
367
368
369
370
371
...
4156
4157
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
2
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
3
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration
4
Mitotane for Adrenocortical Carcinoma: Dosing Guidelines and Therapeutic Drug Monitoring
5
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
6
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
7
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
8
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer
9
Global Update 2026: Selumetinib (KOSELUGO) Expands Indication to Adult NF1-PN and Clinical Management Strategies
10
Lenvatinib Safety Guide: Baseline Assessment & Adverse Reaction Management
11
Inluriyo (Imlunestrant): Oral SERD for ER+/HER2- Breast Cancer with ESR1 Mutations
12
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies